- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06578338
Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children (INFER)
February 2, 2026 updated by: Danone Asia Pacific Holdings Pte, Ltd.
A Study to Collect Data to Build Artificial INtelligence Derived Algorithms For Estimating Height and Weight in childRen (INFER)
An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's height using images taken by a healthcare professional or parents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an exploratory, observation, data-collection study that aims to evaluate the performance of a Height Artificial Intelligence (HAI) algorithm in a real world setting.
Images will be collected by parents or healthcare professionals, together with physical height measurements.
This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements.
Data on the acceptance and experience of using the algorithm will be collected for improvements.
Study Type
Observational
Enrollment (Actual)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore
- KK Women's and Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Children aged above 24 months old and below 6 years of age with no physical deformities
Description
Inclusion Criteria:
- Children aged above 24 months old and below 6 years old.
- Parent(s) should have access to the internet and a smartphone or table to complete study questionnaires, take images and upload images.
- Parent(s) should be able to comprehend the content of the study and complete the study questionnaires in English.
- Written consent from parents and/or legally acceptable representative
Exclusion Criteria:
- Children who are unable to stand upright against a wall
- Children who are unable to cooperate with standing height measurement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children aged above 24 months old and below 6 years of age
Children aged above 24 months old and below 6 years of age with no structural abnormalities of the lower limbs or orthopaedic conditions
|
Physical height will be measured and images will be collected for AI to estimate the height
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of the height AI (cm)
Time Frame: 2 days
|
Accuracy of the Height AI (cm) in a clinic and in a home setting, derived from:
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of the Weight AI (kg)
Time Frame: 2 days
|
Accuracy of the Weight AI (kg) in a clinic and in a home setting, derived from:
|
2 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessments by the parent on usability of the AI in a home-setting via study questionnaire
Time Frame: 2 days
|
|
2 days
|
|
Assessments by the investigator on usability of the AI in a clinic-setting via a questionnaire
Time Frame: 2 days
|
|
2 days
|
|
Assessments by the investigator on ease of collecting images in a clinic-setting via a questionnaire
Time Frame: 2 days
|
Investigator's assessment on the ease of collecting the images [Very Easy, Easy, Normal, Difficult, Very Difficult]
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Fabian Yap, MBBS, KK Women's and Children's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 9, 2024
Primary Completion (Actual)
March 4, 2025
Study Completion (Actual)
March 4, 2025
Study Registration Dates
First Submitted
August 5, 2024
First Submitted That Met QC Criteria
August 27, 2024
First Posted (Actual)
August 29, 2024
Study Record Updates
Last Update Posted (Actual)
February 4, 2026
Last Update Submitted That Met QC Criteria
February 2, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBB20R&31696-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.